Hope in Advanced Myelofibrosis Trial | Philadelphia News

Philadelphia News Today | 2 Min News | The Daily News Now! · Aug 24, 2026 · 1m

Hope is on the horizon for advanced myelofibrosis patients as scientists at Temple University’s Fox Chase Cancer Center test a powerful new combo therapy using two FDA-approved drugs. Designed not to cure, but to dramatically ease debilitating symptoms when all else fails, the treatment targets the root cause of blood cell overproduction. One patient, Demetria Mears, who battled the disease for over a decade, reports feeling “a thousand percent better” after joining the trial — a stunning turnaround from years of crushing fatigue and despair. Doctors are tracking symptom relief closely, and…